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Angiotensin II and NADPH Oxidase Increase ADMA in
Vascular Smooth Muscle Cells
Zaiming Luo, Tom Teerlink, Kathy Griendling, Shakil Aslam,
William J. Welch, Christopher S. Wilcox
Abstract—Asymmetrical dimethylarginine inhibits nitric oxide synthase, cationic amino acid transport, and endothelial
function. Patients with cardiovascular risk factors often have endothelial dysfunction associated with increased plasma
asymmetrical dimethylarginine and markers of reactive oxygen species. We tested the hypothesis that reactive oxygen
species, generated by nicotinamide adenine dinucleotide phosphate oxidase, enhance cellular asymmetrical dimethyl-
arginine. Incubation of rat preglomerular vascular smooth muscle cells with angiotensin II doubled the activity of
nicotinamide adenine dinucleotide phosphate oxidase but decreased the activities of dimethylarginine dimethylamin-
ohydrolase by 35% and of cationic amino acid transport by 20% and doubled cellular (but not medium) asymmetrical
dimethylarginine concentrations (P0.01). This was blocked by tempol or candesartan. Cells stably transfected with
p22phox had a 50% decreased protein expression and activity of dimethylarginine dimethylaminohydrolase despite
increased promoter activity and mRNA. The decreased DDAH protein expression and the increased asymmetrical
dimethylarginine concentration in p22phox-transfected cells were prevented by proteosomal inhibition. These cells had
enhanced protein arginine methylation, a 2-fold increased expression of protein arginine methyltransferase-3 (P0.05)
and a 30% reduction in cationic amino acid transport activity (P0.05). Asymmetrical dimethylarginine was increased
from 61 to 163 mol/L (P0.005) in p22phox-transfected cells. Thus, angiotensin II increased cellular asymmetrical
dimethylarginine via type 1 receptors and reactive oxygen species. Nicotinamide adenine dinucleotide phosphate
oxidase increased cellular asymmetrical dimethylarginine by increasing enzymes that generate it, enhancing the
degradation of enzymes that metabolize it, and reducing its cellular transport. This could underlie increases in cellular
asymmetrical dimethylarginine during oxidative stress. (Hypertension. 2010;56:498-504.)
Key Words: dimethylarginine dimethylaminohydrolase (DDAH)  protein arginine methyltransferase (PRMT)
 tempol  cationic amino acid transferase (CAT)  hypertension
Asymmetrical dimethylarginine (ADMA) inhibits nitricoxide synthase (NOS) and cationic amino acid transport
(CAT).1 ADMA is generated by protein arginine methyltrans-
ferases (PRMTs) and, after proteolysis, cellular ADMA is
metabolized by dimethylarginine dimethylaminohydrolases
(DDAHs) or exported by CATs.2,3 Angiotensin II (Ang II)
can generate reactive oxygen species (ROS) in blood vessels
by activation of nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase.4 Patients with early hypertension or
kidney disease have elevated plasma levels of ADMA and
markers of ROS,5 which may contribute to endothelial
dysfunction and subsequent cardiovascular or renal events.
Although increased ADMA occurs in several conditions
associated with ROS,6 it is unclear how ROS increase
ADMA. Moreover, infusions of Ang II sufficient to increase
ROS have variable effects on plasma ADMA.7–9
The present studies were designed to test the hypothesis
that NADPH oxidase enhances PRMT and/or reduces
DDAH, but that a reduction in CAT activity may limit
cellular ADMA export. First, we assessed the effects of Ang
II on ROS and ADMA in cultured cells. Thereafter, we
investigated the mechanism of NADPH oxidase–induced
changes in ADMA directly in cells stably transfected with
p22phox which increases NADPH oxidase activity.10 We
selected preglomerular vascular smooth muscle cells
(PGVSMCs) because the afferent arteriole is the main resis-
tance vessel in the kidney and generates ROS with Ang II11
and vascular smooth muscle cells (VSMCs) produce little
nitric oxide (NO), which obviates its confounding effects on
DDAH activity.12
Methods
All animal care and experimental procedures complied with National
Institutes of Health guidelines and were approved by Georgetown
University Animal Care and Use Committee. Details of the methods
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are available in the online Data Supplement at http://hyper.
ahajournals.org.
Cell Culture
PGVSMCs were isolated from 13 to 15 week old male WKY rats
purchased from Tacomic Farms (Germantown, NY) as described in
detail (see the online Data Supplement).11
Measurement of Superoxide Production
in PGVSMCs
Cells were seeded into a 96-well plate at densities of 1105 cells per
well in 200 L of the DMEM-F12 medium. After 24 hours, the cells
were incubated overnight in serum-free medium, which was replaced
4 hours before incubation with added vehicle or indicated dose of
Ang II. Measurement of superoxide (O2) was as described in detail
previously for these cells using low concentration (5 mol/L)
lucigenin-enhanced chemiluminescence.11 NADPH oxidase activity
was assessed from the increase in superoxide generated after addition
of 100 mol/L of NADPH.
Overexpression of NADPH Oxidase Subunit
p22phox in Rat PGVSMCs
A full-length rat p22phox cDNA fragment (709 bp) was cloned into
the EcoRI/XbaI site of pcDNA4 HisMax vector which contained
ampicillin and zeocin-resistant genes to allow positive clone (see the
online Data Supplement).
DDAH2 Promoter Activity Assay
The mouse DDAH-2 promoter (924 to 36 bp from transcription
start site) that drives a luciferase construct was cloned into pGL3-
Basic vector (Promega) as described previously.13 This was a gift
from Dr Satoshi Tanaka (University of Tokyo, Japan) (see the online
Data Supplement).
Medium or Cell Lysate ADMA, Symmetrical
Dimethylarginine, and L-Arginine
VSMCs were grown to full confluence in 100-mm dishes and
cultured for 48 hours in 5 mL of serum-free, phenol red–free
medium. Some dishes of cells were directly treated with indicated
dose of Ang II for 48 hours and some of them were pretreated for 2
hours with Candesartan (107 mol/L), CandesartanPD-123,319
(3106 mol/L) or Tempol (104 mol/L) and then coincubated with
vehicle or Ang II (106 mol/L) for 48 hours. Measurement of
ADMA, symmetrical dimethylarginine (SDMA), and L-arginine in
the medium and cell lysate was performed using HPLC as previously
described (see the online Data Supplement).14
Medium H2O2
Measurement of H2O2 released from intact PGVSMCs was per-
formed using Amplex Red hydrogen peroxide/peroxidase assay kit
(Molecular Probes Inc) (see the online Data Supplement).
DDAH Activity
The conversion of [14C]ADMA to [14C]citrulline was used to
quantify DDAH activity based on previous assays (see the online
Data Supplement).15
CAT Activity Assays
CAT activity was assessed in intact cells from 10 mmol/L lysine-
inhibitable [14C]ADMA uptake (see the online Data Supplement).2
RNA Isolation and Real-Time
Quantitative RT-PCR
Real-time quantitative PCR was performed in an ABI Prism 7700
sequence-detection system (Applied Biosystems, Foster City, Calif)
as described (see the online Data Supplement).16
Protein Expression
This used Western blot as described (see the online Data
Supplement).16
Analysis of Protein Carbonylation
The carbonylated proteins from lysed cells were detected with an
OxyBlot Oxidized Protein Detection Kit (Millipore, Billerica, Mass)
as reported previously (see the online Data Supplement).17
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Figure 1. MeanSEM values for PGVSMCs (n6 per group) incu-
bated for 4 hours with angiotensin II showing changes in superox-
ide and the effects of 104 mol/L tempol (A) on asymmetrical dim-
ethylarginine in the medium (open circles) and cell lysate (close
circles) (B) and the effects of coincubation with candesartan (107
mol/L), PD-123,319 (3106 mol/L), or tempol (104 mol/L). Com-
pared to vehicle: *P0.05; **P0.01; ***P0.005.
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Materials
Ang II, tempol, and NADPH were obtained from Sigma-Aldrich
(St Louis, Mo), DMEM-F12 from Gibco (Carlsband, Calif), and
FBS from American Type Culture Collection (Manassas, VA).
Statistical Analysis
Results are expressed as meansSEM. ANOVA was performed, and
differences between experimental groups were compared by Stu-
dent’s t test, when appropriate. A value of P0.05 was considered as
statistically significant.
Results
Ang II produced concentration-dependent increases in cellu-
lar O2 from 1010 mol/L (Figure 1A), confirming prior
findings.11 Cellular ADMA doubled with 106 mol/L Ang II,
but the medium ADMA was modestly reduced (Figure 1B).
Coincubation of Ang II–stimulated cells with candesartan or
tempol reduced cellular ADMA (Figure 1C), which was not
altered by addition of the Ang II type 2 (AT2) receptor
blocker PD-123,319. Ang II increased the activity of NADPH
oxidase (2-fold; P0.01; Figure 2A) but decreased the
activities of DDAH by 35% (P0.01) and CAT by 20%
(P0.05) (Figure 2B and 2C).
Cells stably transfected with p22phox (S-p22phox) had an
increased expression of NOX-1 mRNA (2.40.37-fold;
P0.02) and protein (2.90.1-fold; P0.003) but no signif-
icant changes for NOX-4 (Figure S1 in the online Data
Supplement). Transcripts or protein for NOS-1, -2, or -3 were
not detected in PGVSMCs (data not shown). The S-p22phox
cells had a 2.5-fold increased p22phox (P0.01) and a 2-fold
increased O2 and H2O2 (P0.01; Figure 3). The mRNA for
DDAH-1 and DDAH-2 (Figure 4A) and the DDAH-2 pro-
moter activity (Figure 4B) were increased by 2- to 4-fold
(P0.01) in S-p22phox cells. However, the protein expression
for DDAH-1 and DDAH-2 were reduced by 50% (P0.01;
Figure 4C), and the DDAH activity was reduced correspond-
ingly (P0.01; Figure 4D). S-p22phox cells had a marked
increase in protein carbonyls that was abolished by incuba-
tion with catalase and tempol (Figure S2). After incubation of
S-p22phox cells with 1 mol/L epoxomicin to inhibit proteo-
somal degradation, DDAH-1 and -2 expression increased by
50% (P0.05; Figure S3). This was accompanied by a
reduction in cellular concentrations of ADMA in S-p22phox
cells to the level measured in wild-type (Wt) cells (Figure
S4). The increased mRNA expression for DDAH-1 and -2 in
S-p22phox cells persisted after epoxomicin treatment
(DDAH-1 mRNA 1.60.1-fold increase; P0.02 and
DDAH-2 2.40.3-fold increase; P0.02; data not shown).
There was a marked increase in asymmetrical dimethyla-
tion of proteins in S-p22phox cells and in cells incubated for 30
minutes with 100 mol/L H2O2 (Figure 5A) accompanied by
a doubling of PRMT-3 expression (P0.05; Figure 5B).
CAT activity, assessed as lysine-inhibitable [14C]ADMA
cellular uptake (Figure 6A), was reduced by 30% in S-p22phox
cells (P0.05; Figure 6B), accompanied by a 70% reduction
in CAT-1 mRNA expression (P0.01) that was mimicked by
incubation of Wt cells with H2O2 (Figure 6C).
S-p22phox cells grown in culture medium containing
L-arginine had a 10% increase in medium L-arginine concen-
tration (P0.005), a 60% increase in medium ADMA
(P0.005) and a 5% reduction in medium SDMA (P0.05;
Table). The concentrations in cell water were calculated from
the relationship between cell water and cell protein content in
rat cultured VSMCs.18 S-p22phox cells had a doubling of
cellular L-arginine (P0.005), a 2.6-fold increase in cellular
ADMA (P0.005), and a 3-fold increase in cellular SDMA
(P0.05; Table).
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Figure 2. MeanSEM values (n3 per
group) for cells incubated with a vehicle
(open boxes) or angiotensin II (106 mol/L)
(closed boxes) for NADPH oxidase, DDAH,
and CAT activities after incubation for 4
hours with vehicle or 106 mol/L angioten-
sin II. Compared to vehicle: *P0.05;
**P0.01.
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The cell:medium concentration ratio for L-arginine, ADMA,
and SDMA were all increased significantly (P0.05) in
S-p22phox cells (Table).
Discussion
The main new findings are: Incubation of VSMCs with Ang
II for 4 hours increased O2 and cellular, but not medium,
ADMA. Inhibition of AT1 receptors or ROS blocked the
increase in cellular ADMA. Ang II stimulated NADPH
oxidase but inhibited DDAH and CAT activities. Stable
transfection of cells with p22phox increased mRNA and
protein expression for NOX-1 and increased the ROS gener-
ation, protein arginine methylation, and PRMT-3 expression
but decreased DDAH protein expression and activity, CAT
activity and CAT-1 expression. The decrease in DDAH
protein and activity occurred despite an increase in DDAH
mRNA expression and was prevented by blockade of proteo-
somal degradation which also reduced cellular ADMA of
S-p22phox cells to the level of Wt cells. These changes in
S-p22phox cells were accompanied by an increase in medium
and a greater increase in cellular levels of ADMA.
The function of ADMA in VSMCs is not clear. We could
not detect expression of mRNA or protein for any NOS
isoform in our isolated PGVSMCs. However, ADMA can
have adverse vascular effects in endothelial nitric oxide
synthase knockout mice.19 ADMA can stimulate ROS pro-
duction from some NOS isoforms if arginine is limited or
tetrahydrobiopterin is oxidized.20 Moreover, Vallance and
Leiper1 have shown that ADMA released from 1 cell can
inhibit NOS in an adjacent cell and that this could be a
mechanism for VSMCs to signal to endothelial cells. Addi-
tionally, Ang II doubled the release of ADMA from cultured
endothelial cells.21 Thus, a similar mechanism for angioten-
sin-induced ADMA generation may occur in VSMCs and
endothelial cells, but this remains to be explored.
We found an increase in cellular ADMA with Ang II that
was related to AT1 receptor activation and to ROS. Thus,
cellular O2 and ADMA increased in parallel from 1010
mol/L Ang II and the increase in ADMA was prevented by
candesartan, but not PD-123,319 and by tempol, which
prevented Ang II–stimulated increases in O2 in these
cells.11 A decreased ADMA metabolism by DDAH during
Ang II could contribute to increased cellular ADMA concen-
trations, whereas a decreased CAT activity could reduce
cellular export of ADMA into the medium. Further studies
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focused on the direct effects of prolonged NADPH oxidase
activity on ADMA.
The membrane protein p22phox is a critical component of
NADPH oxidase.10 Smooth muscle specific overexpression
of p22phox in mice increased aortic p22phox and NOX-1
proteins and increased O2 and H2O2 generation,22 whereas
knockdown of p22phox in vivo reduced the protein expression
for NOX-1, -2, and -4.23 Stable transfection of cells with
p22phox provided a robust model of cellular oxidative stress
with increased O2 and H2O2 generation and increased
NOX-1 expression. In apparent contrast to the finding that
Ang II decreased DDAH activity in PGVSMCs, we detected
an increase in the mRNA for DDAH-1 and -2 in S-p22phox
cells accompanied by an increase in the promoter activity for
DDAH-2. However, this was accompanied by a reduction in
protein expression for DDAH-1 and -2 and cellular DDAH
activity. This discrepancy was related to enhanced proteoso-
mal degradation because the reduced protein expression for
DDAH-1 and -2 in S-p22phox cells was mitigated (for
DDAH-1) or prevented (for DDAH-2) by inhibition of
proteosomal degradation by epoxomicin, which also normal-
ized the increased cellular ADMA concentrations. This ex-
tended prior studies in which H2O2 enhanced proteosomal
degradation of the inositol 1,4,5-triphosphate receptor in
VSMCs.24 Because restoration of DDAH-1 or -2 protein
expression with epoxomicin did not correct the increased
mRNA in S-p22phox cells, the increased mRNA was not likely
a compensation for reduced DDAH expression.
Inhibition of DDAH by oxidative stress has been ascribed to
oxidation of a cysteine residue in the catalytic site of the
enzyme1,12 or to downregulation of protein expression.25 A novel
finding was that this also can involve proteosomal degradation
of the DDAH protein. We detected increased asymmetrical
dimethylarginine in proteins and increased PRMT-3 protein
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Table. Concentrations of L-Arginine, ADMA, and SDMA in the Medium and Cell Water of Preglomerular
Vascular Smooth Muscle Cells Transfected With p22phox or Wild-Type Cells Transfected With an Empty Vector
Cell Type Arginine ADMA SDMA
Medium
Wild type 5295 mol  L1 2207 nmol  L1 1436 nmol  L1
S-p22phox 5882 nmol  L1 3574 nmol  L1 1354 nmol  L1
P 0.005 0.005 0.05
Calculated concentrations in cell water, mol  L1*
Wild type 164563 5.91.2 1.60.7
S-p22phox, mol  L1 3222340 15.73.4 4.92.7
P 0.005 0.005 0.05
Cell: medium concentration ratio*
Wild type 3.10.06 26.93.5 11.52.8
S-p22phox 5.50.33 51.913.9 36.112.0
P 0.005 0.05 0.05
MeansSEM (n6 per group). *Based on a cell water content of cultured vascular smooth muscle cells of 2.53 L  mg
protein1.18
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expression in S-p22phox cells, which suggests that increased
PRMT activity contributed to increased cellular ADMA. Re-
cently, Chen et al26 reported that bovine retinal capillary endo-
thelial cells cultured in high-glucose solution that elevated ROS
production had increased PRMT-1 expression and decreased
DDAH activity and DDAH-2 expression. These were corrected
by antioxidants, suggesting that ROS increased PRMT-1 and
decreased DDAH, as in our study.
The finding that Ang II or activation of NADPH oxidase
reduced cellular CAT activity and that the latter reduced
CAT-1 mRNA expression is compatible with prior studies
that have reported diminished CAT activity or expression
under conditions that induce oxidative stress, for example,
exposure to cigarette smoke27 or homocysteine.28
ADMA concentrations in cultured endothelial cells are re-
ported to be10-fold above that in the medium.29 We measured
ADMA concentrations in PGVSMCs to be 27-fold above that in
the medium. The calculated intracellular concentrations of
ADMA of 6 mol/L in Wt cells and 16 mol/L in S-p22phox
cells are expected to inhibit NOS in other cell types that express
NOS isoforms, but the higher calculated intracellular arginine
concentrations would offset this effect. The doubling of intra-
cellular L-arginine in p22phox cells may be secondary to in-
creased cellular proliferation which enhances arginine turnover30
because p22phox overexpression induces proliferation in VSMCs.10
Perspectives
Because Ang II upregulated ROS in many tissues4,11 and ROS
increased cellular ADMA, Ang II should increase ADMA.
Indeed, Ang II doubled ADMA release from cultured endo-
thelial cells. However, we found that relatively short-term
incubation of VSMCs with Ang II for 4 hours did not change,
or even reduced, medium ADMA, despite a rise in cellular
ADMA. This may be a consequence of a reduced CAT
activity which could slow the cellular export of ADMA.
Infusions of Ang II were reported to increase7 or maintain8
plasma ADMA or to increase ADMA only at high rates of
Ang II infusion.9 Our findings in isolated cells suggest that
there could be a substantial increase in cellular ADMA in
conditions that enhance ROS that may not be reflected
reliably in plasma levels because of decreased CAT activity.
The finding that Ang II and NADPH oxidase expression both
reduced CAT activity supports the possibility that in the short
term, ADMA export may be diminished. However, in the
long term, the increased intracellular ADMA will stress the
CAT system and export will increase until a new steady state
has been reached where the rate of ADMA production will
equal the sum of degradation by DDAH and export by CAT.2
The main effect of CAT inhibition is that this steady state
should be reached at higher intracellular levels of ADMA.
ADMA production in S-p22phox cells was increased, as
evidenced by increased PRMT expression and increased
levels of ADMA moieties on proteins. From the Table, it is
apparent that ADMA in the medium increased 1.6-fold
compared to wild-type cells. This is less than the 2.7-fold
increase in intracellular ADMA, compatible with reduced
CAT activity, but clearly shows an increased net export of
ADMA. Thus, under steady-state conditions, export of
ADMA by VSMCs may be increased by ROS, although this
may not hold for other cell types. Uptake of ADMA by
neighboring endothelial cells with NOS inhibition is plausi-
ble, but remains to be demonstrated experimentally.
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Methods 
 
Cell culture:  The phenotype of the cells was confirmed from characteristic morphology 
(hill and valley pattern), Ang II contraction, expression of smooth muscle-specific alpha actin 
and smooth muscle myosin heavy chain and the absence of mRNA for von Willebrand factor 
(endothelial cell marker).  Experiments were conducted between passages 4 and 12.  Cells were 
cultured in DMEM-F12 medium supplemented with 10% fetal bovine serum, 100 u · ml-1 of 
penicillin, 100 mcg · ml-1 of streptomycin and 200 mcg · ml-1 of glutamine at 37ºC.   
 
Overexpression of NADPH oxidase subunit p22phox in rat preglomerular vascular 
smooth muscle cells: Plasmid DNA was purified from an ampicillin-resistant clone. The p22phox 
insertion was confirmed by electrophoresis and sequencing.  The empty pcDNA4 vector alone or 
vector carrying p22phox cDNA (8µg/each) were suspended in 500µl of Opti-MEM I reduced 
serum medium (Invitrogen, Carlsbad, CA) and mixed gently with 500µl of 1:25 diluted 
lipofectamine 2000 (Invitrogen, Carlsbad, CA) to form a nucleic-acid-lipofectamine complex.  
After incubation for 20 min at room temperature, the complex was added to 60-70% confluent 
PGVSMCs seeded in a 60mm plate in 5ml of Opti-MEM I reduced serum medium. After 
incubation at 37ºC for 6h, transfected cells were cultured in DMEM/F-12 medium containing 
15% fetal bovine serum. 48 hours later, transfected cells were split 1:4 into 100-mm plates and 
cultured in regular growth medium with 450µg · ml-1 of zeocin (Invitrogen) for clone selection.  
Zeocin-containing medium was changed every 2 days.  Two weeks after selection, zeocin 
resistant clones were isolated and amplified from the stable transfected cell line (S-p22phox).  The 
wild type (Wt) cells with empty vector and S-p22phox cells were used for experiments or stored in 
-80ºC pending use. 
 
DDAH2 promoter activity assay: The plasmid construction, transfection and DDAH-2 
promoter activity assay were described previously 1. Briefly, both Wt and S-p22phox PGVSMCs 
were seeded in 12-well plates at a density of 3 x 105 cells · cm-2 and incubated in culture medium 
for 24 h.  Cells were transiently transfected with the plasmid DNA or promoter lacking pGI3-
basic vector using lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the 
manufacturer's protocol. Cells were incubated for 48 hours and harvested in passive lysis buffer 
(Promega, Madison, WI). Luciferase activity was measured with luciferase assay substrate and 
normalized by cellular protein concentrations (protein assay reagent; Bio-Rad Laboratories, Inc., 
Hercules, CA).  Each sample was examined in triplicate, and at least three independent 
experiments were performed.  
 
Medium or cell lysate ADMA, SDMA, and L-arginine: After 48-hour of cell culture in 
serum-free, phenol-red-free medium, the conditioned medium was collected in a 15ml sterile 
polypropylene tube and centrifuged at 4°C for 10 min at 2000g , thereafter the supernatant was 
transferred to ice cold 1.5 ml tubes  and stored at -80 °C. Cells were washed three times with ice-
cold PBS, scraped into 5 ml of ice-cold PBS and centrifuged at 500g for 5 min. The pellet was 
resuspended in 250 µl of ice-cold sodium phosphate buffer (100 mM; pH 6.5) on ice for 30 min, 
sonicated on ice with 3 sets of 10 second pulses using a Sonifier Sonicator 250 (Branson; 
Danbury CT, USA; output 3.0, duty cycle 30%), mixed with 250 μl of 1.2 M perchloric acid 
(Sigma, St. Louis, MO) and, after centrifugation (10 minutes at 2,000 g at 4ºC), the supernatant 
was collected and stored at -80 ºC. Concentrations of L-arginine, ADMA and SDMA in medium 
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and lysate were measured by HPLC with fluorescence detection as previously described 2 using 
modified chromatographic separation conditions 3. Supernatants obtained after deproteinization 
of cell lysates with perchloric acid were neutralized with two volumes of 0.5 M Na2HPO4 to one 
volume of the supernatant. Cell lysates and medium were spiked with monomethylarginine as an 
internal standard and purified by solid-phase extraction on polymeric cation-exchange columns. 
Thereafter, the samples were dried with nitrogen, and derivatized with ortho-phthaldialdehyde 
reagent containing 3-mercaptopropionic acid. Analytes were separated by isocratic reversed-
phase HPLC with fluorescence detection. A human plasma pool was analyzed in all analytical 
series as a quality control. For all analytes the intra- and inter-assay coefficients of variation were 
<1.5% and <3.5%, respectively. Lysate concentrations were normalized to protein content. 
 
Medium H2O2: Cells were seeded in a 96-well plate and grown in culture medium. 20 h 
later, 90-95% confluent cells were washed twice with warmed  Krebs-Ringer phosphate glucose 
(KRPG) solution (NaCl 145 mM, sodium phosphate 5.7 mM, KCl 4.86 mM, CalCl2 0.54 mM, 
MgSO4 1.22 mM, glucose 5.5 mM, pH 7.35). 100 µl of reaction mixture containing 50 µM 
Amplex Red reagent and 0.1 U · ml-1 of horseradish peroxidase in KRPG solution was added to 
each well. The fluorescence was measured at an excitation and emission wavelength of 530/580 
nm in a FLUOstar Omega fluorescence reader (BMG Labtech Inc., NC). H2O2 concentration was 
normalized to cellular protein. 
 
DDAH activity: PGSMCs were seeded in 12-well plates at a density of 4 x 105 cells · 
well-1 and incubated in culture medium for 24 hours. Cells were washed 3 times in 37ºC-warmed 
HEPES-buffered Krebs solution (mM: NaCl 131, KCl 5.5, CaCl2 2.5, MgCl2 1.0, NaHCO3 25, 
NaH2PO4 1.0, HEPES 20 and glucose 5.5, pH 7.4). 500 µl of [14C]-labelled ADMA (0.25 µCi/ml, 
specific activity 52 mCi/mM, radio-labelled at C5 position; custom-synthesized by Moravek 
Biochemicals Inc, CA.) in HEPES-buffered Krebs solution was added to each well and the 
culture plates incubated at 37°C in 5% CO2 for 1 h. The reaction solution was removed and cells 
were rinsed 3 times with cold HEPES-buffered Krebs solution and lysed in 500 µl of 0.1% (w/v) 
sodium dodecyl sulphate. 250 µl of cell lysate was assayed by scintillation counting. The 
remainder was mixed with 1 ml of 50% (v/v) activated dowex 50X8-400 cation exchange resin 
(Sigma, St. Louis, MO) that binds cationic amino acids including ADMA and arginine, but not 
citrulline, and centrifuged at 12,000g for 3 min. 400μl of the supernatant containing [14C]-
citrulline was taken for scintillation counting. DDAH activity was calculated as [14C]-citrulline 
generated from [14C]-ADMA.  
 
  CAT activity assays: Cells were prepared as for DDAH activity (above) except that cell 
lysates were not treated with activated dowex 50X8-400 cation exchange resin, but used directly 
for scintillation counting, which represented total [14C]-ADMA uptake by cells. CAT activity 
was reflected by lysine-inhibitable [14C]-ADMA uptake into cells.   
 
RNA isolation and real-time quantitative RT-PCR: Total RNA was isolated with 
RNAqueous-4PCR kit (Ambion  Inc., Austin, TX) following the manufacturer’s instruction 
manual.  Reverse transcription of 1 µg of total RNA / per sample was performed with 
iScriptTMcDNA Synthesis Kit (Bio-Rad, Hercules, CA).  Primers and probes for rat p22phox (ID: 
Rn00377357_m1), DDAH-1, -2 (ID: Rn00574200_m1 and Rn01525776_m1), CAT-1 (ID: 
Rn01453837_m1) and NOS-1,-2,-3 (ID: Rn00583793_m1, Rn00561646_m1 and 
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Rn06132634_s1) were purchased for gene expression assays (Applied Biosystems, Foster City, 
CA) . The comparative [DELTA][DELTA]CT method was used for relative quantification and 
statistical analysis. 
 
 Protein expression: Cells were cultured in 100mm plates with complete medium (see cell 
culture above). After confluence, cells were incubated with serum free DMEM/F-12 for 48 hours. 
Cells were treated with vehicle or reagents for indicated times. Cells were washed 3 times with 
ice cold PBS and thereafter were lysed with mammalian tissue lysis buffer (Sigma St. Louis, 
MO), 50-100 µg of lysates were run on 6-12.5% SDS-PAGE gels (Bio-Rad, Hercules, CA), 
transferred to nitrocellulose membranes, and incubated overnight at 4°C while shaking in 5% 
Blotto with primary antibodies for DDAH-1 (Abcam Inc, Cambridge, MA), DDAH-2 (Sigma, St 
Louis, MO), p22phox (Santa Cruz Biotechnology, Inc, Santa Cruz, CA), NOS-1, -2 and -3 
(Millipore, Billerica, MA), PRMT-1, -3, -4 and -5 (Sigma, St Louis, MO) at 1:500-2000 
dilutions and quantified with horseradish  peroxidase (HRP)-conjugated goat anti-rabbit IgG or 
rabbit anti-mouse or -goat IgG (KPL, Gaithersburg, MD) at 1: 1000-20000 dilution, and probed 
with β-actin antibody to control for equal loading (Sigma, St Louis, MO). The developed films 
were scanned with an imagine densitometer and optical densities of protein bands quantified 
using NIH Image J software (version 1.43, NIH, Bethesda, MD).                         
Determination of protein-incorporated methylated arginine was similar to regular Western 
Blotting as previously described. The mouse monoclonal primary antibody for ADMA was 
purchased from Abcam Inc. (Cambridge, MA). The immunogen for this antibody was 
asymmetric NG-NG-dimethyl arginine (two methyl groups on one of the terminal nitrogen atoms 
of the guanidinium group) and the antibody   reacts with free and bound asymmetric NG-NG-
dimethyl arginine. It is not known whether the antibody reacts with symmetric dimethyl arginine 
(information from manufacturer). Briefly, 100 μg of cell lysates/per lane were run on 12% of 
SDS-PAGE gels and the transferred membranes were incubated in 5% fat-free milk for 1h at 
room temperature  and then in 1:50 diluted primary antibody overnight at 4°C. After washing 3 
times, the membranes were incubated with horseradish peroxidase (HRP)-conjugated anti-mouse 
second antibody at 1:3000 dilution for 1 hour with shaking at room temperature. The following 
procedure was performed as described above. 
 
Analysis of protein carbonylation: Cells were snap-frozen in liquid nitrogen, lysed in 
mammalian tissue lysis buffer (Sigma St. Louis, MO) and centrifuged at 16,000g for 20 min at 
4°C. Carbonyl groups on protein side chains were derivatized with 2,4-dinitrophenylhydrazine 
(DNPH) to form the 2,4-dinitrophenyl (DNP) hydrazone derivative. 30µg of cell lysates were 
denatured with 12% sodium dodecylsulfate (SDS), incubated with DNPH for 15 min, and mixed 
with neutralization solution and ß-mercaptoethanol. For negative control, the same amount of 
cell lysates was incubated with 1x derivatization-control solution in place of DNPH. The samples 
were electrophoresed through a 12.5% SDS-PAGE gel (Bio-Rad, Hercules, CA) and transferred 
to nitrocellulose membranes, blocked with 1% bovine serum albumin for 1 h at room 
temperature and incubated overnight at 4°C with rabbit anti-DNP antibody at 1:150 dilution and 
thereafter with HRP-conjugated goat anti-rabbit IgG at 1:300 dilution for 1 hour at room 
temperature. The carbonylated proteins were determined by an enhanced chemiluminescence 
system (Amersham Biosciences, Piscataway, NJ). 
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Supplemental Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1: Mean ± SEM values (n=3 per group) for NOX-1 and NOX-4 protein and mRNA 
expression, comparing values in wild-type, empty vector transfected cells (Wt) with cells stably 
transfected with p22phox (S-p22phox). Compared to Wt: **, p<0.01; ***, p<0.005.  
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Figure S2: Oxy-blot for protein carbonyls: T+C, tempol plus catalase. 
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Figure S3: Western analysis for DDAH-1 or -2 from wild type (Wt) and p22phox transfected (S-
p22phox) cells cultured with a vehicle (Veh) or with 1M epoxomicin for 6 or 12 hours (n=3 per 
group). Compared to Wt vehicle: *, p<0.05; **, p<0.01; ***, p<0.005.  
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Figure S4: Asymmetric dimethylarginine concentrations in lysates of preglomerular vascular 
smooth muscle cells (n=5 per group) stably transfected with an empty vector (Wt) or p22phox (S-
p22phox) and cultured for 12 hours with a vehicle (Veh) or 1 mol · l-1 epoxomicin (Epx). 
Compared to Wt: ***, p<0.005.  
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